CD4 and systemic lupus erythematosus: In contrast to mTORC2, increased activation of mTORC1 is observed in CD4+ T cells obtained from SLE patients and lupus prone mice leading to elevated IL-17, IL-4 producing double negative T cell expansion and regulatory T cell (Treg) depletion [33–35].